Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin

1 Oct 1993

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Metal complexes synthesis and properties
Share to Trace Elements in Health

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 1327513
DOI: 10.1016/0169-5002(93)90452-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatinPMID 1327513Read ↗

Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsivenessSemantic proximity Read ↗

Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.Semantic proximity Read ↗

Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteinsSemantic proximity Read ↗

Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.Semantic proximity Read ↗

Clinical and molecular features in patients with advanced non-small-cell lung carcinoma refractory to first-line platinum-based chemotherapy.Semantic proximity Read ↗

The effect of acquired cisplatin resistance on sensitivity to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer cells.Semantic proximity Read ↗

Dynamic analysis of pulsed cisplatin identifies effectors of resistance in lung adenocarcinomaSemantic proximity Read ↗

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)Semantic proximity Read ↗

Multidrug resistance characterization in multicellular tumour spheroids from two human lung cancer cell linesSemantic proximity Read ↗

Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.Semantic proximity Read ↗

Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening.Semantic proximity Read ↗

Efficacy of anti-cancer agents in cell lines versus human primary tumour tissueSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.